Nobuyuki Shimizu

Dr. Nobuyuki Shimizu

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2023 in Cells
Verified
Journal Article
Open access
PDF file
NSNobuyuki Shimizu
Nobuyuki Shimizu
HSHiroshi Shiraishi
Hiroshi Shiraishi
THToshikatsu Hanada
Toshikatsu Hanada
Liver diseases represent a significant global health challenge, thereby necessitating extensive research to understand their intricate complexities and to develop effective treatments. In this context, zebrafish (Danio rerio) have emerged as a valuable model organism for studying various aspects of liver disease. The zebrafish liver has striking similarities to the human liver in terms of structure, function, and regenerative capacity. Researchers have successfully induced liver damage in zebrafish using chemical toxins, genetic manipulation, and other methods, thereby allowing the study of disease mechanisms and the progression of liver disease. Zebrafish embryos or larvae, with their transparency and rapid development, provide a unique opportunity for high-throughput drug screening and the identification of potential therapeutics. This review highlights how research on zebrafish has provided valuable insights into the pathological mechanisms of human liver disease.

1 August 2011 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TTToshihiro Tanioka
Toshihiro Tanioka
YTYoshiaki Tamura
Yoshiaki Tamura
MFMakiko Fukaya
Makiko Fukaya
SSShohei Shinozaki
Shohei Shinozaki
JMJi Mao
Ji Mao
MKMasao Kaneki
Masao Kaneki
Insulin receptor substrate-2 (IRS-2) plays a critical role in the survival and function of pancreatic β-cells. Gene disruption of IRS-2 results in failure of the β-cell compensatory mechanism and diabetes. Nonetheless, the regulation of IRS-2 protein expression in β-cells remains largely unknown. Inducible nitric-oxide synthase (iNOS), a major mediator of inflammation, has been implicated in β-cell damage in type 1 and type 2 diabetes. The effects of iNOS on IRS-2 expression have not yet been investigated in β-cells. Here, we show that iNOS and NO donor decreased IRS-2 protein expression in INS-1/832 insulinoma cells and mouse islets, whereas IRS-2 mRNA levels were not altered. Interleukin-1β (IL-1β), alone or in combination with interferon-γ (IFN-γ), reduced IRS-2 protein expression in an iNOS-dependent manner without altering IRS-2 mRNA levels. Proteasome inhibitors, MG132 and lactacystin, blocked the NO donor-induced reduction in IRS-2 protein expression. Treatment with NO donor led to activation of glycogen synthase kinase-3β (GSK-3β) and c-Jun N-terminal kinase (JNK/SAPK) in β-cells. Inhibition of GSK-3β by pharmacological inhibitors or siRNA-mediated knockdown significantly prevented NO donor-induced reduction in IRS-2 expression in β-cells. In contrast, a JNK inhibitor, SP600125, did not effectively block reduced IRS-2 expression in NO donor-treated β-cells. These data indicate that iNOS-derived NO reduces IRS-2 expression by promoting protein degradation, at least in part, through a GSK-3β-dependent mechanism. Our findings suggest that iNOS-mediated decreased IRS-2 expresssion may contribute to the progression and/or exacerbation of β-cell failure in diabetes.

28 May 2024 in Communications Biology
Verified
Journal Article
Open access
PDF file
SLShaohong Lai
Shaohong Lai
HSHiroshi Shiraishi
Hiroshi Shiraishi
WSWulan Apridita Sebastian
Wulan Apridita Sebastian
NSNobuyuki Shimizu
Nobuyuki Shimizu
RURyohei Umeda
Ryohei Umeda
THToshikatsu Hanada
Toshikatsu Hanada
SMG9 is an essential component of the nonsense-mediated mRNA decay (NMD) machinery, a quality control mechanism that selectively degrades aberrant transcripts. Mutations in SMG9 are associated with heart and brain malformation syndrome (HBMS). However, the molecular mechanism underlying HBMS remains unclear. We generated smg9 mutant zebrafish (smg9oi7/oi7) that have a lifespan of approximately 6 months or longer, allowing for analysis of the in vivo function of Smg9 in adults in more detail. smg9oi7/oi7 zebrafish display congenital brain abnormalities and reduced cardiac contraction. Additionally, smg9oi7/oi7 zebrafish exhibit a premature aging phenotype. Analysis of NMD target mRNAs shows a trend toward increased mRNA levels in smg9oi7/oi7 zebrafish. Spermidine oxidase (Smox) is increased in smg9oi7/oi7 zebrafish, resulting in the accumulation of byproducts, reactive oxygen species, and acrolein. The accumulation of smox mRNA due to NMD dysregulation caused by Smg9 deficiency leads to increased oxidative stress, resulting in premature aging.

12 April 2024 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Open access
SMShuya Miyazaki
Shuya Miyazaki
NSNobuyuki Shimizu
Nobuyuki Shimizu
HMHiroaki Miyahara
Hiroaki Miyahara
HTHitoshi Teranishi
Hitoshi Teranishi
RURyohei Umeda
Ryohei Umeda
THToshikatsu Hanada
Toshikatsu Hanada
The DHCR7 enzyme converts 7-DHC into cholesterol. Mutations in DHCR7 can block cholesterol production, leading to abnormal accumulation of 7-DHC and causing Smith-Lemli-Opitz syndrome (SLOS). SLOS is an autosomal recessive disorder characterized by multiple malformations, including microcephaly, intellectual disability, behavior reminiscent of autism, sleep disturbances, and attention-deficit/hyperactivity disorder (ADHD)-like hyperactivity. Although 7-DHC affects neuronal differentiation in ex vivo experiments, the precise mechanism of SLOS remains unclear. We generated Dhcr7 deficient (dhcr7-/-) zebrafish that exhibited key features of SLOS, including microcephaly, decreased neural stem cell pools, and behavioral phenotypes similar to those of ADHD-like hyperactivity. These zebrafish demonstrated compromised myelination, synaptic anomalies, and neurotransmitter imbalances. The axons of the dhcr7-/- zebrafish showed increased lysosomes and attenuated autophagy, suggesting that autophagy-related neuronal homeostasis is disrupted.

Verified
Journal Article
Open access
PDF file
MSMengting Shan
Mengting Shan
MAMagdeline Elizabeth Carrasco Apolinario
Magdeline Elizabeth Carrasco Apolinario
TTTokumaru Tomoko
Tokumaru Tomoko
KSKenshiro Shikano
Kenshiro Shikano
PPPhurpa Phurpa
Phurpa Phurpa
RHReiko Hanada
Reiko Hanada
Metabolic dysfunction-associated steatotic liver disease (MASLD) involves early disturbances such as excessive lipid accumulation, sterile inflammation, and hepatocellular stress. The results of recent studies have highlighted extracellular ATP and its metabolite adenosine (Ado) as damage-associated molecular patterns (DAMPs) that drive inflammation, endoplasmic reticulum (ER) stress, and steatosis, contributing to MASLD progression. Although vitamin E is clinically used for its antioxidant and anti-inflammatory properties, it remains unclear whether its therapeutic effects involve modulation of DAMP-associated signaling. To address this gap, we used transgenic zebrafish expressing a liver-specific G-protein-coupled receptor activation-based adenosine sensor (GRABAdo). We found that a high-cholesterol diet markedly increased hepatic extracellular Ado levels, combined with inflammatory and ER stress-associated gene expression. Vitamin E significantly reduced extracellular Ado levels and hepatic lipid accumulation. Based on RNA sequencing results, vitamin E restored the expression of genes encoding calcium-handling proteins, including atp2a1 and atp1b1b. These genes encode components of the sarco/ER Ca2+-ATPase (SERCA) machinery, which is essential for maintaining ER Ca2+ homeostasis and preventing stress-induced hepatic injury. CDN1163-mediated SERCA activation phenocopied the protective effect of vitamin E, supporting a Ca2+-dependent mechanism. Together, these findings highlight extracellular Ado signaling and impaired SERCA-mediated Ca2+ regulation as early drivers of MASLD and demonstrate that vitamin E ameliorates steatosis by targeting both pathways.

8 August 2016
Verified
Conference Paper
Closed access
KSKeita Soda
Keita Soda
THTakao Hamakubo
Takao Hamakubo
Hiroharu YamashitaHiroharu Yamashita
Hiroharu Yamashita
KCKyungho Chang
Kyungho Chang
NSNobuyuki Shimizu
Nobuyuki Shimizu
Plasma phenomenon has been demonstrated as a new promising tool in medical field, although little is known about the plasma irradiation effects on tissues in abdominal cavity. Therefore finding the possible marker is the first and the key step to evaluate the events after plasma irradiation and a suitable mouse model is required to validate the plasma effects. We focused on abdominal adhesion formation that is the secondary event after surgery irrespective of the any surgical devices, and is associated with complications such as ileus, abdominal pain or infertility. Firstly we generated a mouse abdominal adhesion model using bipolar forceps. Within 7days, cauterized cecum was demonstrated to recruit the epididymal adipose tissue (EAT), which connected tissues abnormally and infiltrated inflammatory cells into EAT were observed by microscopic examination. We also identified some inflammatory proteins released into peritoneal cavity by proteomics of ascites after cauterization. Moreover, we measured serum cytokines level and determined that adhesion could be evaluated as a result of the alteration of pro-inflammatory and anti-inflammatory cytokines. Now we are pursuing to assess the plasma irradiation effects using those inflammatory proteins and cytokines as an appropriate marker.